{"id":"W3168075620","doi":"10.1200/jco.2021.39.15_suppl.3016","title":"A phase I dose-escalation study of the MDM2-p53 antagonist BI 907828 in patients (pts) with advanced solid tumors.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Neutropenia; Tolerability; Pharmacokinetics; Nausea; Pharmacodynamics; Dosing; Internal medicine; Gastroenterology; Pharmacology; Toxicity; Adverse effect","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009180663,0.001360513,0.002090144,0.0004174765,0.0003665763,0.0006862993,0.0006167255,0.0006892538,0.002777069],"category_scores_gemma":[0.0007386626,0.0006095303,0.0006180804,0.0006157556,0.0006138354,0.0005304628,0.0004079498,0.002675695,0.001372109],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000691478,"about_ca_system_score_gemma":0.001085092,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000703005,"about_ca_topic_score_gemma":0.001398258,"domain_scores_codex":[0.9996692,0.0001355327,0.00002123408,0.00006154778,0.00004957752,0.00006299989],"domain_scores_gemma":[0.9995694,0.00006007613,0.0001008285,0.0000403119,0.00002773494,0.0002016431],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4780224,0.1026537,0.01712823,0.001487369,0.001277785,0.000889416,0.0009657283,0.007716923,0.1569564,0.0004794943,0.008110982,0.2243117],"study_design_scores_gemma":[0.3652052,0.5889513,0.02694569,0.00004205746,0.0004543489,0.001091081,0.00009444897,0.002656549,0.007292556,0.0002930525,0.006929962,0.00004373605],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9938126,0.001215859,0.0004921748,0.000272518,0.00004925911,0.001843041,0.0006790539,0.00008757492,0.001547944],"genre_scores_gemma":[0.9908308,0.001183784,0.002051864,0.0004960119,0.00008025598,0.002029805,0.001619939,0.00002704121,0.001680695],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002777069,"threshold_uncertainty_score":0.009290218,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03434385017398364,"score_gpt":0.4115273296264533,"score_spread":0.3771834794524697,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}